Company · CIK 0000882796 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
BIOCRYST PHARMACEUTICALS INC · BCRX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2015 FForm 4 → | Jan 22, 12:12 pm EST | Thomas R Staab IISenior Vice President and CFO | 4,476 | $11.17 | $49,997 | 164,913 | — | plan? |
| Jan 20, 2015 FForm 4 → | Jan 22, 12:10 pm EST | Jon P StonehousePresident & CEO, Director | 10,608 | $11.17 | $118,491 | 654,280 | — | plan? |
| Jan 8, 2015 MForm 4 → | Jan 9, 1:19 pm EST | Fred E CohenDirector | 100,000 | $1.29 | $129,000 | 101,457 | — | plan? |
| Jan 1, 2015 AFForm 4 → | Jan 5, 4:12 pm EST | Alane P BarnesVP, General Counsel & Corp Sec | 7,253 | $12.16 | $29,828 | 74,580 | — | plan? |
| Jan 1, 2015 AFForm 4 → | Jan 5, 4:10 pm EST | Yarlagadda S BabuSenior VP - Drug Discovery | 11,302 | $12.16 | $29,208 | 214,693 | — | plan? |
| Jan 1, 2015 AFForm 4 → | Jan 5, 4:07 pm EST | William P SheridanSenior VP - CMO | 13,635 | $12.16 | $33,258 | 100,683 | — | plan? |
| Jan 1, 2015 AFForm 4 → | Jan 5, 4:05 pm EST | Thomas R Staab IISenior Vice President and CFO | 11,353 | $12.16 | $29,828 | 169,389 | — | plan? |
| Jan 1, 2015 AFForm 4 → | Jan 5, 4:03 pm EST | Jon P StonehousePresident & CEO, Director | 34,052 | $12.16 | $68,728 | 664,888 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 19, 2016 MForm 4 → | Jan 21, 11:04 am EST | Thomas R Staab IISenior Vice President and CFO | 15,000 | — | — | 87,500 | — | |
| Dec 29, 2015 AForm 4 → | Dec 31, 2:18 pm EST | Alane P BarnesVP, General Counsel & Corp Sec | 43,997 | — | — | 43,997 | — | |
| Dec 29, 2015 AForm 4 → | Dec 31, 2:16 pm EST | Yarlagadda S BabuSenior VP - Drug Discovery | 62,573 | — | — | 62,573 | — | |
| Dec 29, 2015 AForm 4 → | Dec 31, 2:13 pm EST | Lynne PowellSenior VP - CCO | 62,573 | — | — | 62,573 | — | |
| Dec 29, 2015 AForm 4 → | Dec 31, 2:11 pm EST | William P SheridanSenior VP - CMO | 71,698 | — | — | 71,698 | — | |
| Dec 29, 2015 AForm 4 → | Dec 31, 2:09 pm EST | Thomas R Staab IISenior Vice President and CFO | 62,573 | — | — | 62,573 | — | |
| Dec 29, 2015 AForm 4 → | Dec 31, 2:07 pm EST | Jon P StonehousePresident & CEO, Director | 162,950 | — | — | 162,950 | — | |
| Sep 25, 2015 AForm 4 → | Sep 29, 3:01 pm EDT | Sanj K PatelDirector | 16,667 | — | — | 16,667 | — | |
| Aug 5, 2015 AForm 4 → | Aug 7, 5:13 pm EDT | Robert Alexander IngramDirector | 18,750 | — | — | 18,750 | — | |
| Jul 15, 2015 MForm 4 → | Jul 17, 9:45 am EDT | Jon P StonehousePresident & CEO, Director | 33,868 | — | — | 416,132 | — | |
| Jun 22, 2015 MForm 4 → | Jun 24, 4:57 pm EDT | Thomas R Staab IISenior Vice President and CFO | 3,750 | — | — | 11,750 | — | |
| Jun 19, 2015 MForm 4 → | Jun 22, 4:48 pm EDT | William P SheridanSenior VP - CMO | 70,389 | — | — | 42,112 | — | |
| Jun 19, 2015 MForm 4 → | Jun 22, 4:34 pm EDT | Jon P StonehousePresident & CEO, Director | 20,000 | — | — | 80,000 | — | |
| Jun 18, 2015 MForm 4 → | Jun 22, 4:38 pm EDT | Thomas R Staab IISenior Vice President and CFO | 9,375 | — | — | 101,760 | — | |
| May 20, 2015 AForm 4 → | May 22, 2:57 pm EDT | Charles A SandersDirector | 15,000 | — | — | 15,000 | — | |
| May 20, 2015 AForm 4 → | May 22, 2:55 pm EDT | Kenneth B Lee Jr.Director | 15,000 | — | — | 15,000 | — | |
| May 20, 2015 AForm 4 → | May 22, 2:53 pm EDT | Nancy J HutsonDirector | 15,000 | — | — | 15,000 | — | |
| May 20, 2015 AForm 4 → | May 22, 2:51 pm EDT | Stanley C ErckDirector | 15,000 | — | — | 15,000 | — | |
| May 20, 2015 AForm 4 → | May 22, 2:49 pm EDT | Fred E CohenDirector | 15,000 | — | — | 15,000 | — | |
| May 20, 2015 AForm 4 → | May 22, 2:46 pm EDT | George B AbercrombieDirector | 15,000 | — | — | 15,000 | — | |
| May 13, 2015 AForm 4 → | Jun 16, 3:32 pm EDT | Alane P BarnesVP, General Counsel & Corp Sec | 17,000 | — | — | 17,000 | — | late |
| May 13, 2015 AForm 4 → | Jun 16, 3:29 pm EDT | Yarlagadda S BabuSenior VP - Drug Discovery | 17,000 | — | — | 17,000 | — | late |
| May 13, 2015 AForm 4 → | Jun 16, 3:27 pm EDT | William P SheridanSenior VP - CMO | 17,000 | — | — | 17,000 | — | late |
| May 13, 2015 AForm 4 → | Jun 16, 3:24 pm EDT | Thomas R Staab IISenior Vice President and CFO | 17,000 | — | — | 17,000 | — | late |
| May 13, 2015 AForm 4 → | Jun 16, 3:22 pm EDT | Jon P StonehousePresident & CEO, Director | 25,000 | — | — | 25,000 | — | late |
| Jan 26, 2015 AForm 4 → | Jan 28, 3:10 pm EST | Lynne PowellSenior VP - CCO | 190,000 | — | — | 190,000 | — | |
| Jan 8, 2015 MForm 4 → | Jan 9, 1:19 pm EST | Fred E CohenDirector | 100,000 | — | — | 0 | — | |
| Jan 1, 2015 AForm 4 → | Jan 5, 4:12 pm EST | Alane P BarnesVP, General Counsel & Corp Sec | 23,200 | — | — | 23,200 | — | |
| Jan 1, 2015 AForm 4 → | Jan 5, 4:10 pm EST | Yarlagadda S BabuSenior VP - Drug Discovery | 42,400 | — | — | 42,400 | — | |
| Jan 1, 2015 AForm 4 → | Jan 5, 4:07 pm EST | William P SheridanSenior VP - CMO | 52,000 | — | — | 52,000 | — | |
| Jan 1, 2015 AForm 4 → | Jan 5, 4:05 pm EST | Thomas R Staab IISenior Vice President and CFO | 42,400 | — | — | 42,400 | — |